Federal Circuit Highlights The Importance Of Separating Claim Construction And Infringement Analysis When Dealing With After-Arising Technology

Novartis Pharmaceuticals Corporation v. Torrent Pharma Inc., No. 23-2218 (Fed. Cir. 2025) - On January 10, 2025, the Federal Circuit reversed the district court's opinion that claims of a Novartis [...]